Ng George K 4

What Happened
George K. Ng, CEO of Processa Pharmaceuticals (PCSA), made an open-market purchase of 2,465 shares on 2026-06-15 at $2.22 per share, for a reported total of approximately $5,472. This was a straightforward purchase (transaction code P), which is generally viewed as a direct buy of company stock rather than a sale or option exercise.

Key Details

• Transaction date: 2026-06-15; Filing date: 2026-06-16 (filed the next day).
• Price: $2.22 per share. Total reported value: ~$5,472.
• Transaction type: Open market purchase (code P).
• Shares owned after transaction: Not specified in the supplied filing summary.
• Footnotes/plan info: No 10b5-1 plan, tax withholding, or other special footnotes were indicated in the provided transaction details.
• Timeliness: Filing appears timely (filed the business day after the transaction).

Context
Open-market purchases are often watched by investors as a more direct signal of insider buying compared with grants or exercises, though a single small purchase like this is limited in size. No derivatives, gifts, or cashless exercises were involved — this was a plain buy on the market.